Telatinib
| CAS No. | 332012-40-5 |
|---|---|
| MDL No. | MFCD18251453 |
| MF | C20H16ClN5O3 |
| MW | 409.80 |
| InChI Key | QFCXANHHBCGMAS-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Telatinib is a furopyridazine derivative with substituents at positions 4 and 7: (4-chlorophenyl)amino and [2-(methylcarbamoyl)pyridin-4-yl]methoxy groups, respectively. It is a potent inhibitor of VEGFR2/3, c-Kit, and PDGFRalpha. It functions as an antineoplastic agent, VEGF receptor antagonist, receptor protein-tyrosine kinase inhibitor (EC 2.7.10.1), apoptosis inducer, and angiogenesis inhibitor. It belongs to the classes of monochlorobenzenes, anilines, furopyridazines, aromatic ethers, and pyridinecarboxamides.
| CAS No. | 332012-40-5 |
|---|---|
| Product Name | Telatinib |
Biological Targets
PDGFRB·KIT·KDR·FLT4
Associated Conditions
neoplasm·gastric cancer
* The information provided here is compiled from public sources and is for reference only.
